Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sinclair signs marketing agreement with Wockhardt
The 10 year agreement with Wockhardt in India initially covers: Atopiclair – non steroidal cream for atopic dermatitis, Aloclair – presentations for the treatment of mouth ulcers, Papulex
The 10 year agreement with Wockhardt in India initially covers: Atopiclair – non steroidal cream for atopic dermatitis, Aloclair – presentations for the treatment of mouth ulcers, Papulex
Under the terms of the agreement, Norgine is granted an exclusive licence to develop and market Colal-Pred in Europe, South Africa, Australia and New Zealand. Alizyme will immediately
The patent protects technology which improves HbA1c stability, precision and accuracy and has resulted in a longer product shelf-life with improved performance. The invention may also have utility
The Phase IIa, double-blind, placebo-controlled clinical study in 124 patients with mild to moderate hypertension has been initiated in the UK. Patients will be given a course of
The positive opinion is based upon the results of five clinical studies – four double-blind placebo-controlled studies and a relapse prevention study – involving more than 2,000 non-depressed
Aerocrine’s method of measuring airway inflammation, using exhaled nitric oxide (NO) tests, has also been incorporated into China’s national guidelines for asthma management. The new guidelines have resulted
Integra’s Tibiaxys plating system has received clearance from the FDA, and a CE Mark certification in the European Union. According to Integra, the Tibiaxys system is designed specifically
The supplemental biologics license application (sBLA) seeks to convert an accelerated approval indication into full approval. It is based on a placebo-controlled Phase III clinical trial to confirm
This novel compound inhibits the Beta-catenin pathway and is a potent inducer of cancer cell death. The company plans to begin clinical testing of AVN316 in patients in
Derma’s Medihoney products consist of 100% active leptospermum honey packaged in a tube, and a patented colloidal sheet referred to as Honeycolloid. The company said that these two